NFIL3 and ovarian carcinoma: CCK8 assays provided clear evidence that NFIL3 overexpression significantly inhibited the proliferation of ovarian cancer (OC) cells, while the use of sgRNA targeting NFIL3 promoted OC cell proliferation (Figure 7E-F).